Using MitraClip as a “bridge-to-transplant” strategy in patients with mitral regurgitation (MR) secondary to advanced heart failure (HF) and limited access to heart transplant (HTx) allowed clinical and hemodynamic stabilization resulting in good clinical outcomes, according to new 2-year data from the MitraBridge study.